SCHEMBL1771696

SCHEMBL1771696

CCCCCC=CCC(CC)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ PPARG P37231 5/20 0.52
▸ PPARD Q03181 4/20 0.52
▸ PPARA Q07869 4/20 0.52
▸ TERT O14746 3/20 0.52
▸ PTPN1 P18031 3/20 0.52
▸ MAPT P10636 3/20 0.52
▸ BLM P54132 3/20 0.52
▸ HSD17B10 Q99714 3/20 0.52
▸ FABP4 P15090 3/20 0.52
▸ TOP1 P11387 3/20 0.52
▸ USP2 O75604 2/20 0.52
▸ LMNA P02545 2/20 0.52
▸ ALOX15 P16050 2/20 0.52
▸ RECQL P46063 2/20 0.52
▸ CYP19A1 P11511 2/20 0.52
▸ NR4A2 P43354 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9845962 1.00 CA2 (0.52) CA2MAPK1PPARGPPARDPPARA
SCHEMBL1771695 1.00 CA2 (0.52) CA2MAPK1PPARGPPARDPPARA
SCHEMBL28843088 0.98 TERT (0.55) PPARGPPARDPPARATERTPTPN1
SCHEMBL21996277 0.98 TERT (0.55) PPARGPPARDPPARATERTPTPN1
SCHEMBL21996276 0.98 TERT (0.55) PPARGPPARDPPARATERTPTPN1
SCHEMBL1875404 0.92 PPARG (0.57) PPARGPPARDPPARATERTPTPN1
SCHEMBL1875405 0.92 PPARG (0.57) PPARGPPARDPPARATERTPTPN1
SCHEMBL28085929 0.87 FFAR1 (0.56) CA2MAPK1PPARGPPARDPPARA
SCHEMBL18951930 0.86 CA2 (0.47) CA2MAPK1TDP1CHRM1FFAR1
SCHEMBL3271003 0.86 CA2 (0.47) CA2MAPK1TDP1CHRM1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075551-A1 PERFUMES AND PERFUME ENCAPSULATES THE PROCTER & GAMBLE COMPANY (US) 2011-06-23 — — WO claimed
WO-2011075556-A1 COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM THE PROCTER & GAMBLE COMPANY (US) 2011-06-23 — — WO claimed
US-20110152147-A1 ENCAPSULATES PROCTER & GAMBLE COMPANY, THE 2011-06-23 — — US disclosed
US-20110152146-A1 ENCAPSULATES THE PROCTER & GAMBLE COMPANY 2011-06-23 — — US disclosed
US-20110111999-A1 HIGH-EFFICIENCY PERFUME CAPSULES THE PROCTER & GAMBLE COMPANY 2011-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110111999-A1 HIGH-EFFICIENCY PERFUME CAPSULES PLIN5, PORCN, PIGS CA2 4349/4885MAPK1 4846/4885PPARG 1067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback